...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the “Shock and Kill” Approach

Re: Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the “Shock and Kill” Approach

posted on Jun 07, 2018 09:55AM

Well, hopefully Resverlogix “Shocked and Killed” it at BIO International. But we have no way of knowing that the company presented, or even attended, based upon the lackluster company communications. Be warned, if you email the company with questions "Please allow 1-2 business days for a reply, at times longer when the team is traveling."

BDAZ

Share
New Message
Please login to post a reply